You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 2, AUGUST 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

EFFECT OF HEXAMETHONIUM (C6) ON RENAL HEMODYNAMICS IN MAN

T. D. ULLMANN, M.D.; D. DIENGOTT, M.D.

AMA Arch Intern Med. 1953;92(2):228-237.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SEVERAL ganglion-blocking agents have been recently recommended for the treatment of essential hypertension. Although a number of reports dealing with the effects of these drugs on the systemic blood pressure and on clinical aspects of the hypertensive state have been published,1 only a few studies have appeared2 on the influence of the drugs on renal function, an important consideration in hypertensive patients for two reasons. On the one hand, if the drug could improve the impaired renal function, and particularly the renal blood flow, this might not only help to minimize further damage, but also might possibly break the postulated "vicious circle," relating persistent systemic hypertension to impaired renal blood flow. On the other hand, if the antihypertensive drugs reduced not only the systemic blood pressure but also the perfusion pressure in the kidneys, functional impairment or even structural damage of the kidneys might result.

The present report . . . [Full Text PDF of this Article]


Author Affiliations

JERUSALEM

From the Medical Department "A" and the Laboratory for Clinical Research, Rothschild Hadassah University Hospital.


Footnotes

Presented in part before the 17th Scientific Congress of the Medical Association of Israel, Haifa, Nov. 25-28, 1952.

Supported in part by grants from the Gottlieb Fund for Kidney Research and from the Teva Middle East Pharmaceutical & Chemical Works, Ltd., Jerusalem.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.